Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Downer EDI – Buy

Posted on | by Leon Hinde

DOW:ASX is now under Algo Engine buy conditions. The company has guided towards double-digit earnings growth into FY22 & FY23.

Downer EDI has found support and buying interest has increased above $5.00.

12/8 Update: Downer EDI has now rallied from $5.00 to $5.80.

Crown – Add to Watchlist

Posted on | by Leon Hinde

The current weakness in the Crown share price could be a buying opportunity. It’s unlikely that the current COVID-related operational impacts are going to deter the interested parties who have put forward takeover offers.

Continue to track the CWN share price and wait for a cross above the 10-day average.

12/8 Update: CWN is now trading above the 10 day average.

Santos – Buy Signal

Posted on | by Leon Hinde

Santos has revised the offer for the merger under which Oil Search investors would receive 0.6275 new Santos shares for each Oil Search share held, implying $4.29 per Oil Search share based on July 19 prices.

The combined entity would become an ASX top-20 company, overtaking Woodside Petroleum as the nation’s largest oil and gas producer.

Northern Star – Buy

Posted on | by Leon Hinde

Northern Star Resources is under Algo Engine buy conditions and is our preferred gold exposure.

NST continues to deliver strong results in the June quarter. Group production finished with 450koz at $1460oz, (up 23%), whilst seeing costs come down almost 10%.

We continue to see the twin factors of a strong gold price and cost-saving, (post-merger with SAR), helping to support the share price.